saperconazole has been researched along with Candidiasis, Vulvovaginal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cauwenbergh, G; De Beule, K; Dhondt, A; Van Cutsem, J | 1 |
1 trial(s) available for saperconazole and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Phase II trial: an evaluation of oral saperconazole in acute vaginal candidosis: a comparison of three dosage schedules.
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Azoles; Candidiasis, Vulvovaginal; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged | 1991 |